« Return to Article Summary

A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients



Article Options

Go To Abstract Disease Markers - Read Full Abstract, Access Prior Issues ... Publisher Link
Print Article Summary
Related Articles MDlinx Article Summaries on Similar Topics from Clinician-Valued Journals

1 Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study Clinical Orthopedics and Related Research, February 2, 2015

2 HIV-positive-to-HIV-positive kidney transplantation -- results at 3 to 5 years New England Journal of Medicine, February 13, 2015    Evidence Based Medicine

3 Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients Urology, February 5, 2015

4 Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients Liver International, February 10, 2015

5 Tenofovir-based preexposure prophylaxis for HIV infection among African women New England Journal of Medicine, February 9, 2015    Evidence Based Medicine

6 Non-alcoholic steatohepatitis and hepatic fibrosis in human immunodeficiency virus-1 mono-infected adults with elevated transaminases on antiretroviral therapy Clinical Infectious Diseases, February 18, 2015

7 Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study The Lancet, February 17, 2015    Evidence Based Medicine

8 Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program Hepatology, February 13, 2015

9 Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings - week 104 analysis of ACTG A5230 Clinical Infectious Diseases, February 20, 2015

10 Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: The TB/HIV in Rio (THRio) study Clinical Infectious Diseases, February 6, 2015